论文部分内容阅读
新生儿ABO溶血病是新生儿早期高胆红素血症最常见的病因之一,患儿可发生胆红素脑病,早期需积极治疗,此病的治疗除常规的治疗外,近年来报道使用静脉用丙种球蛋白(IVIG)可阻断溶血过程,显著降低血总胆红素水平。我们通过监测治疗前后血浆胆红素水平的变化,以观察IVIG治疗新生儿ABO溶血病的疗效。1资料与方法1.1一般资料选择我院2004年3月—2009年4
Neonatal ABO hemolytic disease is one of the most common causes of neonatal hyperbilirubinemia in early neonates, bilirubin encephalopathy can occur in children with early active treatment, the treatment of this disease in addition to conventional treatment, reported in recent years Intravenous gammaglobulin (IVIG) blocks the hemolysis process and significantly reduces the level of total serum bilirubin. We monitored the change of plasma bilirubin levels before and after treatment to observe the effect of IVIG treatment of neonatal ABO hemolytic disease. 1 Materials and Methods 1.1 General Information Select our hospital March 2004 - 2009 4